Literature DB >> 34887334

Advances and Future Directions in Molecular Breast Imaging.

Matthew F Covington1, Ephraim E Parent2, Elizabeth H Dibble3, Gaiane M Rauch4, Amy M Fowler5.   

Abstract

Molecular breast imaging (MBI) using 99mTc-sestamibi has advanced rapidly over the past decade. Technical advances allow lower-dose, higher-resolution imaging and biopsy capability. MBI can be used for supplemental breast cancer screening with mammography for women with dense breasts, as well as to assess neoadjuvant therapy response, evaluate disease extent, and predict breast cancer risk. This article highlights the current state of the art and future directions in MBI.
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  MBI; breast specific γ-imaging; molecular breast imaging; nuclear breast imaging; sestamibi

Mesh:

Year:  2021        PMID: 34887334      PMCID: PMC8717200          DOI: 10.2967/jnumed.121.261988

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   11.082


  45 in total

1.  Lexicon for standardized interpretation of gamma camera molecular breast imaging: observer agreement and diagnostic accuracy.

Authors:  Amy Lynn Conners; Carrie B Hruska; Cindy L Tortorelli; Robert W Maxwell; Deborah J Rhodes; Judy C Boughey; Wendie A Berg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06       Impact factor: 9.236

2.  The Association of Background Parenchymal Enhancement at Breast MRI with Breast Cancer: A Systematic Review and Meta-Analysis.

Authors:  Christopher M Thompson; Indika Mallawaarachchi; Durgesh K Dwivedi; Anoop P Ayyappan; Navkiran K Shokar; Rajkumar Lakshmanaswamy; Alok K Dwivedi
Journal:  Radiology       Date:  2019-06-25       Impact factor: 11.105

3.  Gamma Imaging-Guided Minimally Invasive Breast Biopsy: Initial Clinical Experience.

Authors:  Rachel F Brem; Anita K Mehta; Jocelyn A Rapelyea; Esma A Akin; Adriana M Bazoberry; Christel D Velasco
Journal:  AJR Am J Roentgenol       Date:  2018-01-11       Impact factor: 3.959

4.  Effect of menstrual cycle phase on background parenchymal uptake at molecular breast imaging.

Authors:  Carrie B Hruska; Amy Lynn Conners; Celine M Vachon; Michael K O'Connor; Lynne T Shuster; Adam C Bartley; Deborah J Rhodes
Journal:  Acad Radiol       Date:  2015-06-22       Impact factor: 3.173

5.  The Clinical Utility of a Negative Result at Molecular Breast Imaging: Initial Proof of Concept.

Authors:  Ravi Jain; Deanna R Katz; Amber D Kapoor
Journal:  Radiol Imaging Cancer       Date:  2020-09-25

6.  Reasons for (non)participation in supplemental population-based MRI breast screening for women with extremely dense breasts.

Authors:  S V de Lange; M F Bakker; E M Monninkhof; P H M Peeters; P K de Koekkoek-Doll; R M Mann; M J C M Rutten; R H C Bisschops; J Veltman; K M Duvivier; M B I Lobbes; H J de Koning; N Karssemeijer; R M Pijnappel; W B Veldhuis; C H van Gils
Journal:  Clin Radiol       Date:  2018-06-18       Impact factor: 2.350

7.  Integrin scintimammography using a dedicated breast imaging, solid-state gamma-camera and (99m)Tc-labelled NC100692.

Authors:  Tore Bach-Gansmo; Trond V Bogsrud; Arne Skretting
Journal:  Clin Physiol Funct Imaging       Date:  2008-07-01       Impact factor: 2.273

8.  Background Parenchymal Uptake on Molecular Breast Imaging and Breast Cancer Risk: A Cohort Study.

Authors:  Carrie B Hruska; Jennifer R Geske; Amy Lynn Conners; Dana H Whaley; Deborah J Rhodes; Michael K O'Connor; Rickey E Carter; Christopher G Scott; Celine M Vachon
Journal:  AJR Am J Roentgenol       Date:  2021-03-03       Impact factor: 3.959

9.  Prevalence of mammographically dense breasts in the United States.

Authors:  Brian L Sprague; Ronald E Gangnon; Veronica Burt; Amy Trentham-Dietz; John M Hampton; Robert D Wellman; Karla Kerlikowske; Diana L Miglioretti
Journal:  J Natl Cancer Inst       Date:  2014-09-12       Impact factor: 13.506

10.  Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study.

Authors:  Carrie B Hruska; Christopher G Scott; Amy Lynn Conners; Dana H Whaley; Deborah J Rhodes; Rickey E Carter; Michael K O'Connor; Katie N Hunt; Kathleen R Brandt; Celine M Vachon
Journal:  Breast Cancer Res       Date:  2016-04-26       Impact factor: 6.466

View more
  2 in total

Review 1.  PET-CT in Clinical Adult Oncology: II. Primary Thoracic and Breast Malignancies.

Authors:  Matthew F Covington; Bhasker R Koppula; Gabriel C Fine; Ahmed Ebada Salem; Richard H Wiggins; John M Hoffman; Kathryn A Morton
Journal:  Cancers (Basel)       Date:  2022-05-29       Impact factor: 6.575

Review 2.  Applying artificial intelligence technology to assist with breast cancer diagnosis and prognosis prediction.

Authors:  Meredith A Jones; Warid Islam; Rozwat Faiz; Xuxin Chen; Bin Zheng
Journal:  Front Oncol       Date:  2022-08-31       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.